TCS partners with GlaxoSmithKline

MUMBAI: GlaxoSmithKline (GSK) and Tata Consultancy Services today announced an agreement to establish a global drug development support center here, to help meet the demands of the growing GSK pipeline.

According to the multi-million dollar contract TCS will provide services in clinical research, including Clinical Data Management and Clinical Submissions Support. The partnership will help GSK expand capacity in response to increased efficiency demands, leverage the high-quality talent pool in India, and benefit from cost and process improvements.

The center will house a TCS team of skilled professionals including pharmacologists, PhDs in life sciences, post-graduates in Pharmacy, and individuals with a life sciences background experienced in clinical-data management and programming.

"This strategic partnership with TCS represents a significant step towards GSK's vision of leveraging key talent globally to develop innovative medicines, said Dr Amber Salzman, senior vice president, Development Operations, GSK. "GSK has chosen to partner with TCS because of its strong record in knowledge process outsourcing, underpinned by operational excellence. I am confident our collaboration will benefit both partners and, most important, help to deliver new medicines to patients."

Commenting on the partnership, J Rajagopal, executive vice president and global head- Life Sciences and Healthcare, TCS, said, "The engagement with GSK is an endorsement of TCS's strategy to focus on services supporting the drug development processes and the investments made in building our domain competencies in this area."

The Life Sciences and Healthcare Practice at TCS has over 3200 professionals focused on providing IT consulting, solutions and services to Life Sciences and Healthcare customers across the world.

© CyberMedia News